Liver & Pancreatic Health
Monitor how your liver and pancreas are responding to GLP-1 treatment, weight loss, and metabolic changes.
The Biosensitive® Advanced GLP-1 Blood Test is designed to help you monitor your health, safety, and progress while using GLP-1 weight loss treatments. This comprehensive test tracks how your metabolism, hormones, and nutrient levels respond to medication, helping you identify imbalances that could affect energy or wellbeing. Reviewed by our clinical team, your results provide clear, actionable insights to help you optimise treatment, minimise side effects, and achieve sustainable, long-term weight management success with confidence.
All items are typically dispatched within 24 hours. 30-day return for unopened and unused product tests and kits.
Click on each biomarker to see what it does and how it can influence your health.
A waste product processed by the liver. Elevated levels can indicate liver stress, bile flow issues, or red blood cell breakdown , important when monitoring GLP-1 side effects.
An enzyme related to the liver and bile ducts. Abnormal levels can reflect liver inflammation or blockage, sometimes affected by weight loss, medications, or rapid metabolic change.
A sensitive enzyme released when liver cells become damaged. Helpful for detecting early signs of fatty liver or medication-related liver stress.
Reflects liver enzyme activity and is often elevated with fatty liver disease, alcohol intake, or toxin exposure. Important when assessing metabolic health during GLP-1 use.
Indicates how well the kidneys remove waste. High or low levels can suggest dehydration, high protein breakdown, or impaired kidney function.
Another key kidney marker. Together with eGFR, it helps assess filtration efficiency and hydration status.
The most important indicator of kidney filtration capacity. GLP-1 medications can impact hydration, making kidney monitoring essential.
An enzyme produced by the pancreas to digest fats. Elevated levels may indicate pancreatic irritation — important because GLP-1 medications can occasionally affect the pancreas.
Shows iron storage levels. Low ferritin causes fatigue and poor exercise tolerance; high levels may indicate inflammation or liver stress.
Reflects average blood glucose over 2–3 months. Useful for assessing insulin resistance and monitoring improvements from GLP-1 treatment.
General cholesterol measure used to assess heart and metabolic health.
The “bad” cholesterol that increases cardiovascular risk if elevated.
Includes all harmful cholesterol particles and is a stronger predictor of heart disease than LDL alone.
The “good” cholesterol that helps remove excess lipids from circulation.
A key risk indicator for heart disease and metabolic syndrome.
High triglycerides are linked to insulin resistance and fatty liver, crucial markers during GLP-1 therapy.
Indicates how well the body can clot blood. Abnormal levels may reflect inflammation or bone marrow issues.
Shows platelet size and activity. Can indicate inflammation or changes in bone marrow activity.
Reflects overall protein availability in the body. Low values may signal poor nutrition or liver issues.
Produced by the liver; low levels may mean inflammation, liver disease, or poor nutritional status.
Includes immune and transport proteins — useful for assessing immunity, inflammation, and liver health.
Including your Haemoglobin, Haematocrit, Red Cell Count (RBC), MCV (Mean Corpuscular Volume), MCH (Mean Corpuscular Haemoglobin), MCHC (Mean Corpuscular Haemoglobin Concentration)
White Cell Count (WBC), Neutrophils, Lymphocytes, Monocytes, Eosinophils and Basophils.
GLP-1 medications can create powerful changes in metabolism, appetite, digestion, and weight and these shifts can affect several internal systems. This test is designed to monitor the areas of your health most commonly influenced by GLP-1 treatment, helping you stay safe, balanced, and informed throughout your journey.
Monitor how your liver and pancreas are responding to GLP-1 treatment, weight loss, and metabolic changes.
Check how well your kidneys are filtering and managing hydration during treatment, especially as appetite and fluid intake change.
Track key markers linked to blood sugar control, cardiovascular risk, and metabolic improvements from GLP-1 therapy.
Ensure your nutrient levels and blood cell health remain stable while losing weight and adjusting to appetite changes.
A simple three-step process to get clinically led insights into your health.
Order your Advanced GLP-1 Test and we will send your kit to you the following day. You will then be sent a link to book in your nurse visit if you have opted for this service.
You can choose either to have one of our nurses visit you at your home or workplace for a venous blood draw, or you can arrange the blood draw yourself. Around 98% of our patients choose to use our nurse service.
Once your sample is sent back to us using the prepaid envelope in your test kit, we will produce your results within 3-5 days. You will be provided with a doctors report based on your results.
If you have any other questions please reach out to us directly.
GLP-1 treatments can affect your liver, pancreas, kidney function, blood sugar regulation, and nutrient status. This test monitors the biomarkers most likely to change during treatment, helping ensure that you’re responding safely and effectively.
This panel can identify early signs of:
Yes. Improvements in cholesterol, HbA1c, inflammation markers, and nutrient balance can indicate effective metabolic response. Your results will help you understand how your internal health is changing as you lose weight.
Our GLP-1 test looks specifically for the biomarkers which could be affected during your treatment.
This Advanced GLP-1 panel measures:
Yes. We recommend fasting for 8 hours before your sample. Water is okay.
Nurse home visit or you can arrange a venous blood draw yourself. Our Nurse home visit is highly recommended, a qualified nurse collects your blood sample for you and brings it back to our lab.
2-5 days.
Yes, it’s ideal as a baseline test before treatment. This helps your clinician compare how your biomarkers change over time and tailor your plan more safely whilst on medication.
It can help. Markers such as lipase, liver enzymes, electrolyte balance, and nutrient levels may highlight why you’re experiencing nausea, fatigue, digestive changes, or reduced appetite during GLP-1 therapy.
Our clinical team highlights any out-of-range markers and provides guidance on whether you should adjust lifestyle, discuss treatment changes, or follow up with your GP.
Your cart is currently empty.
Start Shopping